PerkinElmer to Acquire Evotec Technologies
PerkinElmer, Inc. announced that it has signed a definitive agreement with Evotec AG to acquire its majority owned subsidiary, Evotec Technologies GmbH, in a cash transaction valued at approximately EUR 23 million. The transaction is subject to regulatory approvals and other customary closing conditions, and is targeted to be completed in the first quarter of 2007.
Through this acquisition, PerkinElmer will provide its customers in the pharmaceutical, biotechnology and academic arenas with Evotec Technologies' high content screening (HCS) instruments and software.
Most read news
Topics
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.